ꢀ
Z. Wrobel, B. Wilk and A. Kwast
Tetrahedron xxx (xxxx) xxx
(EI) m/z 356 (59, [M]þ), 206 (100), 190 (35); HRMS (EI) m/z calcd for
(m, 2H), 7.62e7.65 (m, 2H), 7.76e7.79 (m, 2H), 7.84e7.88 (m, 2H);
C
21H16N4O2 356.1273; found, 356.1278.
13C NMR (125 MHz, CDCl3)
d 28.0, 57.9, 81.7, 123.0, 124.3, 125.3,
127.2, 128.5, 128.6, 129.4, 132.3, 138.7, 142.6, 151.36, 151.41, 171.15;
4.2.4. 2-{4-[(4-Methoxyphenyl)diazenyl]phenyl}-2-
phenylpropanenitrile 4d
MS (EI) m/z 452 (13), 450 (13, [M]þ), 351 (64), 349 (62), 165 (60), 57
79
(100); HRMS (ESI) m/z calcd for C
H
24 23
BrN2O2, [M]þ 4500943;
Obtained from 1a, 2a and 3d, condition F. Yield: 106 mg (31%);
found, 450.0939.
orange crystals, mp. 98e100 ꢀC. 1H NMR (500 MHz, CDCl3)
d 2.14 (s,
3H), 3.89 (s, 3H), 6.99e7.03 (m, 2H), 7.31e7.35 (m, 1H), 7.36e7.42
(m, 4H), 7.50e7.53 (m, 2H), 7.84e7.88 (m, 2H), 7.90e7.93 (m, 2H);
4.2.10. tert-Butyl {4-[(4-bromophenyl)diazenyl]-3-
chlorophenyl}(phenyl)acetate 4j
13C NMR (125 MHz, CDCl3)
d
28.1, 46.1, 55.6, 114.3, 122.9, 123.1,
Obtained from 1c, 2d and 3a, condition C. Yield: 199 mg (41%);
124.9, 126.6, 127.4, 128.1, 129.0, 140.9, 143.1, 146.9, 151.1, 162.3.
HRMS (ESI) m/z calcd for C22H20N3O, [MþH]þ 342.1606; found,
342.1608.
red oil. 1H NMR (500 MHz, CDCl3)
d
1.51 (s, 9H), 4.98 (s, 1H),
7.32e7.42 (6H), 7.56e7.57 (m, 1H), 7.67e7.71 (m, 3H), 7.85e7.88 (m,
2H); 13C NMR (125 MHz, CDCl3)
28.0, 57.6, 82.0, 117.4, 124.7, 126.0,
d
127.5, 127.7, 128.5,128.8,130.9, 132.4, 135.7, 138.0, 143.7, 147.4, 151.5,
4.2.5. 2-{4-[(4-Bromophenyl)diazenyl]-3-methoxyphenyl}-2-
phenylpropanenitrile 4e
170.6; MS (EI) m/z 486 (7), 484 (5, [M]þ), 351 (64), 385 (100), 383
79
(83), 165 (50); HRMS (ESI) m/z calcd for C
H
24 22
Br35ClN2O2, [M]þ
Obtained from 1a, 2b and 3a, condition H. Yield: 176 mg (42%);
484.0553; found, 484.0544.
orange crystals, mp.121e122 ꢀC. 1H NMR (600 MHz, CDCl3)
d 2.13 (s,
3H), 3.98 (s, 3H), 6.98 (dd, J ¼ 8.4, 2.0 Hz, 1H), 7.13 (d, J ¼ 1.8 Hz, 1H),
4.2.11. 1-(4-Bromophenyl)-2-{4-[1-(4-chlorophenyl)-1-
(phenylsulfonyl)ethyl]phenyl}diazene 4k
7.31e7.35 (m, 1H), 7.36e7.42 (m, 4H), 7.60e7.63 (m, 3H), 7.75e7.78
(m, 2H); 13C NMR (150 MHz, CDCl3)
d
28.0, 46.4, 56.5, 111.6, 117.4,
Obtained from 1d, 2a and 3a, condition F. Yield: 167 mg (31%);
119.0, 122.9, 124.5, 125.4, 126.6, 128.2, 129.0, 132.3, 140.5, 141.4,
145.8, 151.7, 157.1; MS (EI) m/z 421 (50), 419 (49, [M]þ), 264 (35),
249 (40), 206 (100); HRMS (EI) m/z calcd for C22H18N739Br 419.0633;
found, 419.0637.
orange crystals, mp. 149e150 ꢀC (hexane/EtOAc); 1H NMR
(500 MHz, CDCl3)
d 2.12 (s, 3H), 7.27e7.32 (m, 4H), 7.38 (d,
J ¼ 7.4 Hz, 2H), 7.38 (d, J ¼ 8.6 Hz, 2H), 7.50 (t, J ¼ 7.4 Hz, 1H),
7.62e7.67 (m, 4H), 7.80e7.83 (m, 4H); 13C NMR (125 MHz, CDCl3)
d
26.0, 74.6, 122.5, 124.4, 125.8, 128.2, 128.3, 130.3, 130.9, 132.4,
4.2.6. 2-{4-[(4-Bromophenyl)diazenyl]-2-chlorophenyl}-2-
phenylpropanenitrile 4f
133.6, 134.5, 136.1, 137.5, 141.9, 151.2, 151.8; HRMS (ESI) m/z calcd for
79
C
H
26 20
Br35ClN2O2SNa [MþNa]þ 561.0015; found, 561.0044.
Obtained from 1a, 2c and 3a, condition F. Yield: 132 mg (31%);
orange crystals, mp. 134e135 ꢀC. 1H NMR (500 MHz, CDCl3)
d
2.20
(s, 3H), 7.29 (m, 5H), 7.67e7.68 (m, 2H), 7.81e7.84 (m, 3H),
7.93e7.96 (m, 2H); 13C NMR (125 MHz, CDCl3)
29.3, 45.6, 121.3,
4.2.12. 1-(4-Bromophenyl)-2-(2-methoxyphenyl)diazene 6c
Obtained from 1a, 2b and 3a, condition F, as by-product along
with 4e. Yield 75 mg (26%); orange crystals, mp. 80e81 ꢀC. (lit[21]
d
122.4, 124.6, 124.9, 126.4, 127.8, 128.8, 128.9, 132.5, 135.5, 138.9,
140.4, 151.0, 152.7; MS (EI) m/z 425c(78), 423 (66, [M]þ), 240 (73),
190 (60), 183 (69), 155 (100); HRMS (ESI) m/z calcd for
81.5e82.5 ꢀC); 1H NMR (500 MHz, CDCl3)
d 4.02 (s, 3H), 7.01 (ddd,
J ¼ 8.0, 7.3, 1.2 Hz, 1H), 7.10 (dd, J ¼ 8.4, 1.2 Hz, 1H), 7.46 (dd, J ¼ 8.4,
7.3, 1.7 Hz, 1H), 7.61e7.64 (m, 2H), (dd, J ¼ 8.0, 1.7 Hz, 1H), 7.77e7.80
C
21H15N739Br35Cl 423.0138; found, 423.0137.
(m, 2H); 13C NMR (125 MHz, CDCl3)
d 56.3, 112.8, 116.9, 120.8, 124.4,
125.1, 132.2, 132.9, 142.1, 151.8, 157.1; MS (EI) m/z 292 (30), 290 (31,
4.2.7. 2-{4-[(4-Bromophenyl)diazenyl]phenyl}-3-methyl-2-
phenylbutanenitrile 4g
[M]þ), 186 (20), 185 (29), 184 (22), 183 (29), 157 (40), 155 (41), 135
79
(48), 77 (100); HRMS (ESI) m/z calcd forC
H
13 11
BrN2O [M]þ
Obtained from 1a, 2e and 3a, condition H. Yield: 142 mg (34%);
290.0055; found, 290.0065.
orange oil. 1H NMR (600 MHz, CDCl3)
d
1.11 (d, J ¼ 1.7 Hz, 3H), 1.12
(d, J ¼ 1.7 Hz, 3H), 2.97 (sep, J ¼ 1.7 H, 1H), 7.26e7.29 (m, 1H),
7.33e7.38 (m, 2H), 7.51e7.54 (m, 2H), 7.62e7.67 (m, 4H), 7.75e7.79
4.3. General procedure for the reaction of 1-chloroethyl phenyl
sulfone (1e) or phenylacetonitrile (1f) with nitroarenes 2 and
diazonium salts 3
(m, 2H), 7.85e7.89 (m, 2H); 13C NMR (150 MHz, CDCl3)
d 19.1, 34.9,
59.1, 120.4, 123.3, 124.4, 125.7, 126.7, 127.5, 127.8, 129.0, 132.3, 139.2,
124.9,151.2,151.5; MS (EI) m/z 419 (53), 417 (53, [M]þ), 377 (99), 375
(100), 192 (91)190 (72); HRMS (EI) m/z calcd for C23H20N739Br
417.0841; found, 417.0840.
A solution of t-BuOK (56 mg, 0.55 mmol) in dry DMF (6.0 mL)
was cooled down under nitrogen to ꢁ40 ꢀC. To that mixture, a
solution of 1e (102 mg, 0.5 mmol) in DMF (1.0 mL) was added,
followed by the addition of the nitroarene 2 (1.0 mmol) in DMF
(1.0 mL). The mixture was stirred at that temperature for 2 min then
a solution of diazonium tetrafluoroborate 3 (1.2 mmol) in cold N-
methylpyrrolidone (1.0 mL) was added over ca 3e4 s. Neat Et3N
(0.5 mL) was added, the cooling bath was removed and the mixture
was allowed to reach room temperature. The reaction was
quenched by pouring the mixture into saturated aqueous NH4Cl
(50 mL), the resulted mixture was diluted with water (100 mL),
extracted with EtOAc (3 ꢂ 30 mL). The extracts were washed with
water (3 ꢂ 70 mL) and dried with Na2SO4. The solution was evap-
orated and the residue was separated by column chromatography
on SiO2 using hexane/EtOAc mixtures as eluent.
4.2.8. 2-{4-[(4-Bromophenyl)diazenyl]-3-chlorophenyl}-2-
phenylpropanenitrile 4h
Obtained from 1b, 2a and 3a, condition H. Yield: 86 mg (20%);
orange crystals, mp. 90e92 ꢀC (i-PrOH); 1H NMR (500 MHz, CDCl3)
d
2.13 (s, 3H), 7.33e7.38 (m, 2H), 7.39e7.42 (m, 4H), 7.85 (d,
J ¼ 2.1 Hz, 1H), 7.64e7.69 (m, 3H), 7.82e7.85 (m, 2H); 13C NMR
(125 MHz, CDCl3) d 27.9, 45.9, 118.0, 122.5, 124.8, 125.9, 126.5, 128.4,
128.9, 129.2, 132.5, 135.9, 140.0, 145.3, 147.9, 151.4; MS (EI) m/z 425
(85), 423 (67, [M]þ), 240 (66), 183 (71), 155 (100); HRMS (EI) m/z
calcd for C21H15N739Br35Cl 423.0138; found, 423.0134.
4.2.9. tert-Butyl {4-[(4-bromophenyl)diazenyl]phenyl}(phenyl)
acetate 4i
4.3.1. 1-(4-Bromophenyl)-2-{2,4-dichloro-6-[1-chloro-1-
(phenylsulfonyl)ethyl]phenyl}diazene 7a
Obtained from 1c, 2a and 3a, condition D. Yield: 209 mg (51%);
orange crystals, mp.112e114 ꢀC. 1H NMR (500 MHz, CDCl3)
d
1.46 (s,
Obtained from 1e, 2e and 3a along with 8a. Yield: 79 mg (30%);
9H), 4.99 (s, 1H), 7.26e7.29 (m, 1H), 7.31e7.35 (m, 4H), 7.44e7.47
orange crystals, mp. 133e134 ꢀC; 1H NMR (500 MHz, CDCl3)
d 2.18
6